Does the FDA guidance apply to all HRT types

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, guidance applies to all prescription hormone therapy products that contain estrogen or estrogen plus a progestogen. It does not apply to supplements or to compounded hormones from specialty pharmacies. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

How FDA guidance applies across different HRT types

According to FDA.gov, a consistent safety framework applies to every commercially available hormone therapy product. This means the same rules, warnings, and labeling standards apply whether the estrogen is a pill, patch, gel, spray, ring, or vaginal insert. It also applies to progesterone or progestin products used together with estrogen when a woman has a uterus.

According to FDA-approved prescribing information, the FDA evaluates the active hormone, not the brand or delivery method. If a product contains estrogen, or estrogen plus a progestogen, it falls under FDA guidance regarding benefits, risks, and recommended lowest-dose, shortest-use principles. A qualified prescriber should be consulted for decisions about individual therapy.

Which HRT types are included

• Oral estrogen (estradiol tablets, conjugated estrogens)
• Transdermal estrogen (patches, gels, sprays)
• Vaginal estrogen that is absorbed systemically (higher dose rings or creams)
• Combination estrogen-progestogen products (pills, patches)
• Prescription micronized progesterone or progestins used with systemic estrogen

Which HRT types are not fully covered

• Low-dose vaginal estrogen for purely local symptoms. These are FDA approved but treated separately, because they stay mostly in the vaginal tissue and have minimal bloodstream absorption.
• Compounded bioidentical hormones. These are not commercially available, standardized products and are not required to follow FDA safety labeling. They have not been tested for consistency or long-term safety in the same manner as commercially available products.
• Over-the-counter supplements marketed as "hormone balancers." These are not hormone therapy products and are not regulated as such.

Why this matters for you

According to FDA.gov, when warnings or recommendations for hormone therapy are issued, they refer specifically to FDA-approved estrogen and estrogen-progestogen products. Within that group, the FDA does not rank one form as safer than another; instead, each woman's risk may depend on her health history, dose, and route. Low-dose vaginal estrogen has its own, much lighter safety profile according to FDA-approved prescribing information. A qualified prescriber should be consulted to evaluate individual risk and determine appropriate therapy.